Sadly, you should be suspicious because this "article" is just a gloss of the university's press release (and university press releases are notoriously worthless).
The clue is phrases like "a cure rate of 98.6 percent". First of all in any therapy that's an extraordinary number. But in face what's a "cure"? Typically a study has specific endpoints; in oncology (not my specialty) they'll be things like 5 year survival, tumor size reduction etc.
SBRT appears to be effective for small, contained tumors apparently like prostate cancer, so that part is great.
It gets worse in oncology, you often see stuff like progression free survival. This means it is possible for a treatment to provide no actual extension of life, merely improve quality of that life and still be held up as great.
Quality of life is great but sometimes what exactly a treatment is giving you gets lost in the PR wash
I wish articles about this sort of thing would highlight the researchers more. If there is anyone deserving of public fame, it's the people who work to cure cancer!
The clue is phrases like "a cure rate of 98.6 percent". First of all in any therapy that's an extraordinary number. But in face what's a "cure"? Typically a study has specific endpoints; in oncology (not my specialty) they'll be things like 5 year survival, tumor size reduction etc.
SBRT appears to be effective for small, contained tumors apparently like prostate cancer, so that part is great.